Announced Fri, 31 Jul · 17:35 IST
Q1 FY27 Results, Record Date 16 Sept for Dividend, Rs 50 Cr Loan to Subsidiary
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹374.50
prior close
₹375.75
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-1.7-2.1-2.0-2.9-2.9-4.5+1.2+0.4-0.1-5.5-0.1——
Up moveDown movePending
AI summary
SMS Pharma's board approved Q1 FY27 results with standalone revenue up 5.6 percent year on year to Rs 206.96 crore and net profit up about 16 percent to Rs 21.13 crore. Consolidated PAT was Rs 20.91 crore. Fixed 16 Sept as record date for FY26 dividend, AGM on 23 Sept. Re-appointed MD Ramesh Babu Potluri for 5 years. Approved Rs 50 crore unsecured loan to subsidiary SMS Peptides, subject to shareholder approval. Auditor issued a clean limited review.
Likely market impact
Dividend eligibility locked at 16 Sept record date. Steady earnings growth. Rs 50 Cr inter-corporate loan is a related-party transaction needing shareholder nod.